• LL-37 Peptides Combat Multidrug-Resistant Acinetobacter baum

  2026-07-30

  The reference study demonstrates that the human antimicrobial peptide LL-37 and its fragments possess potent antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii. These results highlight the therapeutic potential of peptide-based interventions for hospital-associated, drug-resistant infections.

• Deconstructing Rapid Genotyping: Mechanistic Insights and Ne

  2026-07-30

  Explore the Genotyping Kit for target alleles of insects, tissues, fishes and cells—a transformative tool for rapid, robust PCR-based genotyping. This article uncovers the mechanistic science behind single-tube DNA extraction and connects recent advances in barrier biology to practical assay innovation.

• Dehydroabietic Acid: Dual PPAR-α/γ Agonist in Metabolic Rese

  2026-07-29

  Dehydroabietic acid stands out as a potent dual PPAR-α/γ agonist, powering innovative experimental workflows for lipid metabolism regulation and insulin sensitivity improvement. This guide translates latest reference breakthroughs into actionable protocols and troubleshooting strategies for metabolic disorder research.

• Peripheral Macrophages Drive Pain Sensitization in Sleep Apn

  2026-07-29

  Chivers et al. illuminate how peripheral macrophages mediate persistent pain through nociceptor priming in mice exposed to chronic intermittent hypoxia, modeling obstructive sleep apnea. Their findings establish immune cells as key contributors to pain comorbidities in sleep disorders, guiding future therapeutic strategies targeting neuroimmune interactions.

• HIV-1 Remodels Nuclear Pores to Infect Resting T Cells via C

  2026-07-28

  This study uncovers how HIV-1 overcomes the nuclear pore barrier in resting T cells through cell–cell spread (CCS), activating CD4–LCK–CDK1 signaling to license infection. The findings clarify previously unresolved mechanisms of HIV-1 permissivity in non-dividing T cells and reshape our understanding of viral dissemination in vivo.

• Busulfan in Translational Research: Mechanisms & Strategic W

  2026-07-28

  This thought-leadership article explores Busulfan’s mechanistic roles as a DNA alkylating agent, its pivotal function in senescence and germ cell depletion models, and its strategic value for translational researchers. By critically examining recent dual recombinase tracing studies, including the latest evidence that refutes postnatal neo-oogenesis in mice, we provide actionable protocol insights and competitive positioning. The article uniquely bridges mechanistic depth with workflow optimization and translational outlook, positioning Busulfan from APExBIO as a cornerstone reagent for advanced reproductive and cellular aging studies.

• Redefining Tagging: HA Peptide as a Translational Catalyst

  2026-07-27

  This thought-leadership article explores how the Influenza Hemagglutinin (HA) Peptide transcends routine protein detection, offering mechanistic clarity and strategic guidance for translational researchers. We integrate the latest mechanistic findings in cancer biology, practical protocol parameters, and comparative workflow insights to position the APExBIO HA tag peptide as a benchmark for high-impact molecular workflows.

• STING Activation and Targeted PDT Suppress Breast Cancer Met

  2026-07-27

  This study presents a nanoparticle system combining MHI148-guided photodynamic therapy with 2'3'-cGAMP-mediated STING activation to combat breast cancer metastasis and recurrence. The approach enhances dendritic cell maturation and T cell infiltration, achieving potent type I interferon responses and systemic antitumor immunity.

• HyperFluor 488 Goat Anti-Mouse IgG: Precision in Immunodetec

  2026-07-26

  HyperFluor 488 Goat Anti-Mouse IgG (H+L) Antibody enables high-sensitivity, multiplexed protein detection across immunofluorescence, flow cytometry, and western blotting. As a fluorescently labeled secondary antibody, it delivers robust signal amplification and reproducibility, making it indispensable for applications ranging from neuroepigenetic discovery to routine cell assays.

• Methylation in Neurological Disorders: Insights from SAMe Pa

  2026-07-25

  This review by Bottiglieri et al. synthesizes evidence on the central role of methylation—especially via S-adenosylmethionine (SAMe)—in neurological and psychiatric disorders. The study highlights the biochemical interplay between methyl donors, folate antagonism, and neuropsychiatric outcomes, offering a framework for targeted mechanistic research in neurobiology.

• CTP Solution in In Vitro Transcription: Protocols & Innovati

  2026-07-24

  CTP Solution (100 mM) from APExBIO empowers high-yield, high-fidelity in vitro transcription workflows, critical for advanced mRNA therapeutics like p21 mRNA-LNPs for bladder cancer. This article dissects experimental design, troubleshooting, and translational applications, highlighting the product’s unmatched purity and workflow compatibility.

• Vitamin C Inhibits Cochlear Cell Senescence via ROS/NF-κB Pa

  2026-07-24

  Xu et al. (2024) demonstrate that vitamin C significantly reduces D-galactose-induced senescence in HEI-OC1 cochlear hair cells by suppressing the ROS/NF-κB pathway. These findings suggest a mechanistic basis for vitamin C as a modulator of oxidative stress and inflammation in age-related hearing loss models.

• Ruxolitinib Phosphate Triggers Mitochondrial Cell Death in A

  2026-07-23

  This study reveals that Ruxolitinib phosphate (INCB018424) induces apoptosis and GSDME-mediated pyroptosis in anaplastic thyroid carcinoma (ATC) by inhibiting DRP1-driven mitochondrial fission through the JAK1/2-STAT3 pathway. These findings highlight a novel mechanistic axis linking JAK/STAT signaling to mitochondrial dynamics and suggest translational potential for JAK inhibition in highly aggressive solid tumors.

• Levofloxacin: Mechanisms, Resistance, and Bone Research Util

  2026-07-23

  Levofloxacin is a synthetic fluoroquinolone antibiotic that inhibits bacterial DNA gyrase, halting DNA replication and providing broad-spectrum antibacterial activity. It is also applied in osteoblast growth and chondrocyte metabolism assays. This article details chemical, mechanistic, and workflow parameters, with explicit focus on resistance benchmarks and research integration.

• STING agonist-1: Precision Activation for B Cell Immunology

  2026-07-22

  STING agonist-1 empowers immunology researchers to dissect B cell-driven mechanisms in cancer and inflammation, with proven compatibility across advanced workflows. This article demystifies its use in TLS formation, highlights protocol optimizations, and translates breakthrough mechanistic insights into actionable lab strategies.

458 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page